Physician profile
Ian Rothbauer
NPI 1801394846
$855.31
in general payments reported to CMS, 2019-2025
10 companies · $86.08 in 2025
The $86.08 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.45 · 2020: $139 · 2021: $125 · 2022: $174 · 2023: $50.31 · 2024: $210 · 2025: $86.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $266.47 | 2024-2025 | |
| Nobel Biocare USA | $145.77 | 2019-2022 | |
| Ultradent Products INC | $132.20 | 2019-2021 | |
| Septodont INC. | $102.53 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $65.89 | 2022-2023 | Seglentis |
| Dentsply Sirona INC | $65.58 | 2020-2025 | Cerec, Smartlite Focus |
| Voco America INC. | $41.15 | 2022-2025 | Admira Fusion X-Tra, Meron Plus Qm, Futurabond U |
| Henry Schein, INC. | $13.50 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $11.91 | 2019 | |
| Ivoclar Vivadent, INC. | $10.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Rothbauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.